ALEXION PHARMACEUTICALS INC 4

Accession 0000899866-14-000031

CIK 0000899866operating

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:57 PM ET

Size

36.1 KB

Accession

0000899866-14-000031

Insider Transaction Report

Form 4

Period: 2014-02-03

ALEXION PHARMACEUTICALS INCALXN

MATHIS LARRY

Director

Transactions

Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−30,000→ 0 total
Exercise: $18.08From: 2008-08-09Exp: 2018-05-09→ Common Stock, par value $.0001 per share (30,000 underlying)
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$96.35/sh+1,712$164,951→ 31,168 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$88.40/sh+3,237$286,151→ 34,405 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$49.43/sh+5,572$275,424→ 39,977 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$26.64/sh+7,932$211,308→ 47,909 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$18.01/sh+30,000$540,300→ 90,185 total
Sale
Common Stock, par value $.0001 per share
2014-02-03$155.23/sh−15,020$2,331,555→ 95,165 total
Sale
Common Stock, par value $.0001 per share
2014-02-03$159.01/sh−13,501$2,146,794→ 29,456 total
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−1,712→ 1,713 total
Exercise: $96.35From: 2013-08-07Exp: 2023-05-07→ Common Stock, par value $.0001 per share (1,712 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−5,572→ 0 total
Exercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (5,572 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−7,932→ 0 total
Exercise: $26.64From: 2010-08-12Exp: 2020-05-12→ Common Stock, par value $.0001 per share (7,932 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−12,276→ 0 total
Exercise: $16.83From: 2009-08-13Exp: 2019-05-13→ Common Stock, par value $.0001 per share (12,276 underlying)
Sale
Common Stock, par value $.0001 per share
2014-02-03$158.41/sh−30,222$4,787,467→ 42,957 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$16.83/sh+12,276$206,605→ 60,185 total
Exercise/Conversion
Common Stock, par value $.0001 per share
2014-02-03$10.84/sh+20,000$216,800→ 110,185 total
Sale
Common Stock, par value $.0001 per share
2014-02-03$156.24/sh−9,664$1,509,903→ 85,501 total
Sale
Common Stock, par value $.0001 per share
2014-02-03$157.35/sh−12,322$1,938,867→ 73,179 total
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−3,237→ 0 total
Exercise: $88.40From: 2012-08-08Exp: 2022-05-08→ Common Stock, par value $.0001 per share (3,237 underlying)
Exercise/Conversion
Option to Purchase Common Stock
2014-02-03−20,000→ 10,000 total
Exercise: $10.84From: 2007-08-03Exp: 2017-05-03→ Common Stock, par value $.0001 per share (20,000 underlying)

Footnotes (5)

[F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $155.00 - $155.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
[F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $156.00 - $156.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
[F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $157.00 - $157.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
[F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $158.00 - $158.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
[F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.00 - $159.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Documents

1 file

4
wf-form4_139164825449593.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000899866

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 7:57 PM ET
Size: 36.1 KB

View on SEC.gov